Ophthalmology

Mental Health Scores Decreased in Patients Who Developed POAG

June 18th 2025

Patients with type 2 diabetes had a lower risk of glaucoma when they used glucagon-like peptide 1 (GLP-1) receptor agonists across multiple studies.

Glaucoma in older individual | Image credit: Africa Studio - stock.adobe.com

Corneal Curvature Measurements Significantly Affected by Dry Eye

June 11th 2025

Eye | Image credit: mik_cz - stock.adobe.com

Punctal Plugs Effective, Safe in Treating Moderate, Severe Dry Eye Disease

June 3rd 2025

Dry eye | Image credit: Dragana Gordic - stock.adobe.com

Lower Odds of Cataract Associated With Antioxidant Index

May 28th 2025

Cataracts | Image credit: Africa Studio - stock.adobe.com

May 14th 2025

Continuing Medical Education

View All

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Ophthalmology/Optometry

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

More News

November 17th 2021

Pain, Anxiety Represent Barriers to Anti-VEGF Therapies for Costly Eye Conditions

Pain and fear/anxiety were the most common barriers to anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration and diabetic macular edema. Another study found that those conditions had a significant impact on patients’ quality of life and Medicare costs.

November 15th 2021

Study Identifies Alcohol Use as Potential Risk Factor for AMD Subtype

A new study provides genetic evidence that increased alcohol intake may be a causal risk factor for geographic atrophy, a type of advanced age-related macular degeneration (AMD), but doctors caution it may be too soon to advise patients about the risk.

November 13th 2021

Dr William Katowitz Discusses Pediatric Ophthalmic Surgical Decisions

Surgical decisions with children who have ophthalmic conditions need buy in from parents, but also the children as they get older, said William Katowitz, MD, attending surgeon in the Division of Ophthalmology at Children's Hospital of Philadelphia.

November 12th 2021

Uveitic Macular Edema Increases Costs Among Patients With Noninfectious Uveitis

Rose McNulty

Uveitic macular edema is common in patients with noninfectious uveitis, and its significant burden on patients and payers warrants more specific treatment guidelines to minimize quality-of-life and economic effects.

November 5th 2021

Investigators Identify Childhood Myopia as Potential Crisis During COVID-19

The increase in childhood myopia during the COVID-19 pandemic represents a potential public health crisis, said authors of a study.

November 4th 2021

Music May Lessen Need for Anesthesia During Cataract Surgery, Study Finds

A recent study found that hypertensive events and anesthesia use may be reduced when patients listen to music before cataract surgery.

October 29th 2021

Dr Rajesh Rajpal on Recovery From Cataract Surgery, Employer Considerations

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the timeline of recovery for patients with cataract undergoing corrective surgery.

October 25th 2021

Novel Port Delivery System With Ranibizumab Approved in Wet AMD

The first-of-its-kind port delivery system with ranibizumab serves as the first wet age-related macular degeneration (AMD) treatment in 15 years to provide an alternative to frequent eye injections.

October 23rd 2021

Ranibizumab Linked With Extensive Lapses in Care for Proliferative Diabetic Retinopathy

Approximately half of patients with proliferative diabetic retinopathy exhibited long lapses in care when prescribed ranibizumab across a 5-year follow-up.

October 21st 2021

Ophthalmology Overview: First Nasal Spray for Dry Eye Disease, Surgical Outcomes in Pediatric Patients, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

October 14th 2021

Ophthalmology Overview: How Chronic Pain Impacts the Cornea, Dry Eye Disease in Postmenopausal Women, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

October 11th 2021

Study Finds Significant Price Transparency Concerns for Ophthalmologic Procedures

An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.

October 7th 2021

Ophthalmology Overview: Novel Technology for Dry Eye Disease, Causes of Macular Degeneration, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

October 5th 2021

Young-Onset Type 2 Diabetes Linked With Higher Risk of Retinopathy in Men

Male patients with young-onset type 2 diabetes were found to be at 72% greater risk of retinopathy compared with those who received a diagnosis at 50 years or older.

September 30th 2021

Ophthalmology Overview: Virtual Training for Diabetic Retinopathy, Impact of Blurry Vision, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

September 28th 2021

Insulin Pump Use Linked With Decreased Risk of Diabetic Retinopathy in Young Patients With T1D

Risk of diabetic retinopathy (DR) was found to be decreased in young patients with type 1 diabetes (T1D) who were treated with insulin pumps, with findings also indicating a 2.1-fold greater risk of DR in Black participants compared with White individuals.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.

September 24th 2021

Dr Rajesh Rajpal on the Future of Eye Lens Technology, Cataract Surgery

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.

September 20th 2021

Development of Myopia Found to Accelerate in Young Schoolchildren Amid Pandemic

Incidence and risk of myopia development were found to rise significantly among young Chinese schoolchildren who were exposed to environmental changes caused by COVID-19 between grades 2 to 3.

September 17th 2021

Ophthalmology Overview: Training With Virtual Reality, Refractive Error in Children, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

September 15th 2021

Comorbid Ophthalmic, Systemic Conditions Linked With Higher Risk of Dementia

People with both ophthalmic and systemic conditions were found to be at higher risk of dementia compared with those with only 1 such condition. Some ophthalmic conditions—age-related macular degeneration, cataract, and diabetes-related eye disease—also increased risk on their own.

September 11th 2021

Dr Rajesh Rajpal Reviews Latest Innovations in Cataract Surgery

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the surgical options available to patients undergoing cataract surgery.

September 10th 2021

School-Based Vision Program Shown to Improve Short-term Academic Performance in Adolescents

Students in grades 3 to 7 who were given eyeglasses as part of a school-based vision program were found to achieve better reading scores and exhibit improved academic achievement over 1 year.

September 2nd 2021

Ophthalmology Overview: Managing a Practice, Weight Loss Lessens Risk of Cataract, and More

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

August 31st 2021

Study Finds Increased Dosage of Timolol-Dorzolamide Fixed Combination Safe, Effective in Open-Angle Glaucoma

Increasing the dosage of timolol-dorzolamide fixed combination from twice a day to 3 times a day was found to be safe and significantly more effective in reducing intraocular pressure in patients with open-angle glaucoma, although further research on safety may be warranted.

Rajesh Rajpal, Johnson & Johnson Vision.

August 27th 2021

Dr Rajesh Rajpal on Eye Health Implications of Visual Needs in Younger Populations

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.

August 25th 2021

Study Finds Significant Glaucoma Surgery, Mortality Risk Link in Elderly Patients

Elderly patients who underwent surgery for glaucoma had a greater risk of all-cause and cause-specific mortality than those who did not have surgery, including greater risk of cancer and neurologic cause–related mortality.

August 24th 2021

Presurgery Corticosteroids May Worsen Conjunctival Hyperemia Post Trabeculectomy

Jared Kaltwasser

A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy.

August 21st 2021

Aflibercept Likely to Improve Severity, Complications of Nonproliferative Diabetic Retinopathy

Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.

August 19th 2021

Low Safety Risk Observed in Office-Based, Operating Room Anti-VEGF Intravitreal Injections